InvestorsHub Logo

HDGabor

05/26/22 1:51 PM

#378577 RE: dogn #378576

d-

"Prepayments for exclusive rights on new drugs" for Vascepa in each of 2017-2021 totaling 716M RMB ($106.25M USD).

It is a BS item, so the balance is YTD (is not for the period). 176,333 RMB was paid.

Best,
G